Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks
Objectives To examine the performance of screening for hypertensive disorders in pregnancy by a combination of the maternal factor‐derived a‐priori risk with the uterine artery (UtA) pulsatility index (PI) and to determine whether it is best in such screening to use the mean PI of the two arteries,...
Gespeichert in:
Veröffentlicht in: | Ultrasound in obstetrics & gynecology 2009-08, Vol.34 (2), p.142-148 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 148 |
---|---|
container_issue | 2 |
container_start_page | 142 |
container_title | Ultrasound in obstetrics & gynecology |
container_volume | 34 |
creator | Poon, L. C. Y. Staboulidou, I. Maiz, N. Plasencia, W. Nicolaides, K. H. |
description | Objectives
To examine the performance of screening for hypertensive disorders in pregnancy by a combination of the maternal factor‐derived a‐priori risk with the uterine artery (UtA) pulsatility index (PI) and to determine whether it is best in such screening to use the mean PI of the two arteries, the highest PI or the lowest PI.
Methods
This was a prospective screening study for pre‐eclampsia (PE) requiring delivery before 34 weeks (early PE), late PE and gestational hypertension (GH) in women attending their routine first hospital visit in pregnancy at 11 + 0 to 13 + 6 weeks of gestation. Maternal history was recorded and color flow Doppler imaging was used to measure the left and right UtA‐PI. The performance of screening for PE and GH by a combination of the maternal factor‐derived a‐priori risks determined in a previous study and the UtA‐PI was assessed.
Results
There were 8061 (96.4%) cases unaffected by PE or GH, 37 (0.4%) that developed early PE, 128 (1.5%) with late PE and 140 (1.7%) with GH. The lowest, mean and highest UtA‐PI were significantly higher in early PE and late PE than in the controls (P < 0.0001) and in early PE than late PE (P < 0.0001). The lowest UtA‐PI was higher in GH than in controls (P = 0.014). The best performance in screening was provided by the lowest PI. The detection rate of early PE at a 10% false‐positive rate increased from 47% in screening by maternal factors alone to 81% in screening by maternal factors and the lowest UtA‐PI. The respective detection rates for late PE increased from 41% to 45% and those for GH increased from 31% to 35%.
Conclusions
The patient‐specific risk for PE and GH can be derived by combining the disease‐specific maternal factor‐derived a‐priori risk with the measurement of the lowest UtA‐PI in a multivariate regression model. Copyright © 2009 ISUOG. Published by John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/uog.6452 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733574689</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733574689</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4172-4447935c9615ff88dba9fd609902d917803ba086f83d61a504cf7602797fd8f53</originalsourceid><addsrcrecordid>eNp90LtOxDAQBVALgWB5SHwBcoOgCYwfsWM6tDwlJBooqCJvMl4ZskmwN6B0_AN_yJeQhRVUUE1z5l7pErLL4IgB8OOumR4pmfIVMmJSmQQ0pKtkBEZBopXhG2QzxkcAUFKodbLBjJLSSD0iD1d9i2GOdfQvSEsfm1BiiNTXtA04rW1d9Cc0FgGx9vWUTnrazTH4Gqkd3kJPz5q2rTBQO6eMfby9M0FfEZ_iNllztoq4s7xb5P7i_G58ldzcXl6PT2-SQjLNEymlNiItjGKpc1lWTqxxpQJjgJeG6QzExEKmXCZKxWwKsnBaAddGuzJzqdgiB9-5bWieO4zzfOZjgVVla2y6mGshUi1VZgZ5-K9kwIZUwQ380iI0MQZ0eRv8zIZ-QPli8nyYPF9MPtC9ZWo3mWH5C5cbD2B_CWwsbOXCsKmPP46zjEuhF53Jt3v1FfZ_Fub3t5dfxZ-aoJaj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017973290</pqid></control><display><type>article</type><title>Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Poon, L. C. Y. ; Staboulidou, I. ; Maiz, N. ; Plasencia, W. ; Nicolaides, K. H.</creator><creatorcontrib>Poon, L. C. Y. ; Staboulidou, I. ; Maiz, N. ; Plasencia, W. ; Nicolaides, K. H.</creatorcontrib><description>Objectives
To examine the performance of screening for hypertensive disorders in pregnancy by a combination of the maternal factor‐derived a‐priori risk with the uterine artery (UtA) pulsatility index (PI) and to determine whether it is best in such screening to use the mean PI of the two arteries, the highest PI or the lowest PI.
Methods
This was a prospective screening study for pre‐eclampsia (PE) requiring delivery before 34 weeks (early PE), late PE and gestational hypertension (GH) in women attending their routine first hospital visit in pregnancy at 11 + 0 to 13 + 6 weeks of gestation. Maternal history was recorded and color flow Doppler imaging was used to measure the left and right UtA‐PI. The performance of screening for PE and GH by a combination of the maternal factor‐derived a‐priori risks determined in a previous study and the UtA‐PI was assessed.
Results
There were 8061 (96.4%) cases unaffected by PE or GH, 37 (0.4%) that developed early PE, 128 (1.5%) with late PE and 140 (1.7%) with GH. The lowest, mean and highest UtA‐PI were significantly higher in early PE and late PE than in the controls (P < 0.0001) and in early PE than late PE (P < 0.0001). The lowest UtA‐PI was higher in GH than in controls (P = 0.014). The best performance in screening was provided by the lowest PI. The detection rate of early PE at a 10% false‐positive rate increased from 47% in screening by maternal factors alone to 81% in screening by maternal factors and the lowest UtA‐PI. The respective detection rates for late PE increased from 41% to 45% and those for GH increased from 31% to 35%.
Conclusions
The patient‐specific risk for PE and GH can be derived by combining the disease‐specific maternal factor‐derived a‐priori risk with the measurement of the lowest UtA‐PI in a multivariate regression model. Copyright © 2009 ISUOG. Published by John Wiley & Sons, Ltd.</description><identifier>ISSN: 0960-7692</identifier><identifier>ISSN: 1469-0705</identifier><identifier>EISSN: 1469-0705</identifier><identifier>DOI: 10.1002/uog.6452</identifier><identifier>PMID: 19644947</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Arterial hypertension. Arterial hypotension ; Arteries ; Arteries - diagnostic imaging ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cardiovascular system ; Color ; Diseases of mother, fetus and pregnancy ; Doppler effect ; Epidemiologic Methods ; Female ; Gestation ; gestational hypertension ; Growth hormone ; Gynecology ; Gynecology. Andrology. Obstetrics ; Hospitals ; Humans ; Hypertension ; Hypertension, Pregnancy-Induced - diagnostic imaging ; Hypertension, Pregnancy-Induced - epidemiology ; Hypertension, Pregnancy-Induced - physiopathology ; imaging ; Investigative techniques, diagnostic techniques (general aspects) ; Medical sciences ; Obstetrics ; Pre-eclampsia ; Pregnancy ; Pregnancy Trimester, First ; Pregnancy-Associated Plasma Protein-A - analysis ; Pregnancy. Fetus. Placenta ; Regression analysis ; screening ; Ultrasonic investigative techniques ; Ultrasonography, Doppler, Color - standards ; Ultrasonography, Doppler, Color - utilization ; Ultrasonography, Prenatal - standards ; Ultrasonography, Prenatal - utilization ; Ultrasound ; uterine artery Doppler ; Uterus ; Uterus - blood supply</subject><ispartof>Ultrasound in obstetrics & gynecology, 2009-08, Vol.34 (2), p.142-148</ispartof><rights>Copyright © 2009 ISUOG. Published by John Wiley & Sons, Ltd.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4172-4447935c9615ff88dba9fd609902d917803ba086f83d61a504cf7602797fd8f53</citedby><cites>FETCH-LOGICAL-c4172-4447935c9615ff88dba9fd609902d917803ba086f83d61a504cf7602797fd8f53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fuog.6452$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fuog.6452$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21824370$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19644947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poon, L. C. Y.</creatorcontrib><creatorcontrib>Staboulidou, I.</creatorcontrib><creatorcontrib>Maiz, N.</creatorcontrib><creatorcontrib>Plasencia, W.</creatorcontrib><creatorcontrib>Nicolaides, K. H.</creatorcontrib><title>Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks</title><title>Ultrasound in obstetrics & gynecology</title><addtitle>Ultrasound Obstet Gynecol</addtitle><description>Objectives
To examine the performance of screening for hypertensive disorders in pregnancy by a combination of the maternal factor‐derived a‐priori risk with the uterine artery (UtA) pulsatility index (PI) and to determine whether it is best in such screening to use the mean PI of the two arteries, the highest PI or the lowest PI.
Methods
This was a prospective screening study for pre‐eclampsia (PE) requiring delivery before 34 weeks (early PE), late PE and gestational hypertension (GH) in women attending their routine first hospital visit in pregnancy at 11 + 0 to 13 + 6 weeks of gestation. Maternal history was recorded and color flow Doppler imaging was used to measure the left and right UtA‐PI. The performance of screening for PE and GH by a combination of the maternal factor‐derived a‐priori risks determined in a previous study and the UtA‐PI was assessed.
Results
There were 8061 (96.4%) cases unaffected by PE or GH, 37 (0.4%) that developed early PE, 128 (1.5%) with late PE and 140 (1.7%) with GH. The lowest, mean and highest UtA‐PI were significantly higher in early PE and late PE than in the controls (P < 0.0001) and in early PE than late PE (P < 0.0001). The lowest UtA‐PI was higher in GH than in controls (P = 0.014). The best performance in screening was provided by the lowest PI. The detection rate of early PE at a 10% false‐positive rate increased from 47% in screening by maternal factors alone to 81% in screening by maternal factors and the lowest UtA‐PI. The respective detection rates for late PE increased from 41% to 45% and those for GH increased from 31% to 35%.
Conclusions
The patient‐specific risk for PE and GH can be derived by combining the disease‐specific maternal factor‐derived a‐priori risk with the measurement of the lowest UtA‐PI in a multivariate regression model. Copyright © 2009 ISUOG. Published by John Wiley & Sons, Ltd.</description><subject>Arterial hypertension. Arterial hypotension</subject><subject>Arteries</subject><subject>Arteries - diagnostic imaging</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular system</subject><subject>Color</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Doppler effect</subject><subject>Epidemiologic Methods</subject><subject>Female</subject><subject>Gestation</subject><subject>gestational hypertension</subject><subject>Growth hormone</subject><subject>Gynecology</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension, Pregnancy-Induced - diagnostic imaging</subject><subject>Hypertension, Pregnancy-Induced - epidemiology</subject><subject>Hypertension, Pregnancy-Induced - physiopathology</subject><subject>imaging</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Medical sciences</subject><subject>Obstetrics</subject><subject>Pre-eclampsia</subject><subject>Pregnancy</subject><subject>Pregnancy Trimester, First</subject><subject>Pregnancy-Associated Plasma Protein-A - analysis</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Regression analysis</subject><subject>screening</subject><subject>Ultrasonic investigative techniques</subject><subject>Ultrasonography, Doppler, Color - standards</subject><subject>Ultrasonography, Doppler, Color - utilization</subject><subject>Ultrasonography, Prenatal - standards</subject><subject>Ultrasonography, Prenatal - utilization</subject><subject>Ultrasound</subject><subject>uterine artery Doppler</subject><subject>Uterus</subject><subject>Uterus - blood supply</subject><issn>0960-7692</issn><issn>1469-0705</issn><issn>1469-0705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90LtOxDAQBVALgWB5SHwBcoOgCYwfsWM6tDwlJBooqCJvMl4ZskmwN6B0_AN_yJeQhRVUUE1z5l7pErLL4IgB8OOumR4pmfIVMmJSmQQ0pKtkBEZBopXhG2QzxkcAUFKodbLBjJLSSD0iD1d9i2GOdfQvSEsfm1BiiNTXtA04rW1d9Cc0FgGx9vWUTnrazTH4Gqkd3kJPz5q2rTBQO6eMfby9M0FfEZ_iNllztoq4s7xb5P7i_G58ldzcXl6PT2-SQjLNEymlNiItjGKpc1lWTqxxpQJjgJeG6QzExEKmXCZKxWwKsnBaAddGuzJzqdgiB9-5bWieO4zzfOZjgVVla2y6mGshUi1VZgZ5-K9kwIZUwQ380iI0MQZ0eRv8zIZ-QPli8nyYPF9MPtC9ZWo3mWH5C5cbD2B_CWwsbOXCsKmPP46zjEuhF53Jt3v1FfZ_Fub3t5dfxZ-aoJaj</recordid><startdate>200908</startdate><enddate>200908</enddate><creator>Poon, L. C. Y.</creator><creator>Staboulidou, I.</creator><creator>Maiz, N.</creator><creator>Plasencia, W.</creator><creator>Nicolaides, K. H.</creator><general>John Wiley & Sons, Ltd</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200908</creationdate><title>Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks</title><author>Poon, L. C. Y. ; Staboulidou, I. ; Maiz, N. ; Plasencia, W. ; Nicolaides, K. H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4172-4447935c9615ff88dba9fd609902d917803ba086f83d61a504cf7602797fd8f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Arterial hypertension. Arterial hypotension</topic><topic>Arteries</topic><topic>Arteries - diagnostic imaging</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular system</topic><topic>Color</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Doppler effect</topic><topic>Epidemiologic Methods</topic><topic>Female</topic><topic>Gestation</topic><topic>gestational hypertension</topic><topic>Growth hormone</topic><topic>Gynecology</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension, Pregnancy-Induced - diagnostic imaging</topic><topic>Hypertension, Pregnancy-Induced - epidemiology</topic><topic>Hypertension, Pregnancy-Induced - physiopathology</topic><topic>imaging</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Medical sciences</topic><topic>Obstetrics</topic><topic>Pre-eclampsia</topic><topic>Pregnancy</topic><topic>Pregnancy Trimester, First</topic><topic>Pregnancy-Associated Plasma Protein-A - analysis</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Regression analysis</topic><topic>screening</topic><topic>Ultrasonic investigative techniques</topic><topic>Ultrasonography, Doppler, Color - standards</topic><topic>Ultrasonography, Doppler, Color - utilization</topic><topic>Ultrasonography, Prenatal - standards</topic><topic>Ultrasonography, Prenatal - utilization</topic><topic>Ultrasound</topic><topic>uterine artery Doppler</topic><topic>Uterus</topic><topic>Uterus - blood supply</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poon, L. C. Y.</creatorcontrib><creatorcontrib>Staboulidou, I.</creatorcontrib><creatorcontrib>Maiz, N.</creatorcontrib><creatorcontrib>Plasencia, W.</creatorcontrib><creatorcontrib>Nicolaides, K. H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Ultrasound in obstetrics & gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poon, L. C. Y.</au><au>Staboulidou, I.</au><au>Maiz, N.</au><au>Plasencia, W.</au><au>Nicolaides, K. H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks</atitle><jtitle>Ultrasound in obstetrics & gynecology</jtitle><addtitle>Ultrasound Obstet Gynecol</addtitle><date>2009-08</date><risdate>2009</risdate><volume>34</volume><issue>2</issue><spage>142</spage><epage>148</epage><pages>142-148</pages><issn>0960-7692</issn><issn>1469-0705</issn><eissn>1469-0705</eissn><abstract>Objectives
To examine the performance of screening for hypertensive disorders in pregnancy by a combination of the maternal factor‐derived a‐priori risk with the uterine artery (UtA) pulsatility index (PI) and to determine whether it is best in such screening to use the mean PI of the two arteries, the highest PI or the lowest PI.
Methods
This was a prospective screening study for pre‐eclampsia (PE) requiring delivery before 34 weeks (early PE), late PE and gestational hypertension (GH) in women attending their routine first hospital visit in pregnancy at 11 + 0 to 13 + 6 weeks of gestation. Maternal history was recorded and color flow Doppler imaging was used to measure the left and right UtA‐PI. The performance of screening for PE and GH by a combination of the maternal factor‐derived a‐priori risks determined in a previous study and the UtA‐PI was assessed.
Results
There were 8061 (96.4%) cases unaffected by PE or GH, 37 (0.4%) that developed early PE, 128 (1.5%) with late PE and 140 (1.7%) with GH. The lowest, mean and highest UtA‐PI were significantly higher in early PE and late PE than in the controls (P < 0.0001) and in early PE than late PE (P < 0.0001). The lowest UtA‐PI was higher in GH than in controls (P = 0.014). The best performance in screening was provided by the lowest PI. The detection rate of early PE at a 10% false‐positive rate increased from 47% in screening by maternal factors alone to 81% in screening by maternal factors and the lowest UtA‐PI. The respective detection rates for late PE increased from 41% to 45% and those for GH increased from 31% to 35%.
Conclusions
The patient‐specific risk for PE and GH can be derived by combining the disease‐specific maternal factor‐derived a‐priori risk with the measurement of the lowest UtA‐PI in a multivariate regression model. Copyright © 2009 ISUOG. Published by John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>19644947</pmid><doi>10.1002/uog.6452</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-7692 |
ispartof | Ultrasound in obstetrics & gynecology, 2009-08, Vol.34 (2), p.142-148 |
issn | 0960-7692 1469-0705 1469-0705 |
language | eng |
recordid | cdi_proquest_miscellaneous_733574689 |
source | Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Arterial hypertension. Arterial hypotension Arteries Arteries - diagnostic imaging Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cardiovascular system Color Diseases of mother, fetus and pregnancy Doppler effect Epidemiologic Methods Female Gestation gestational hypertension Growth hormone Gynecology Gynecology. Andrology. Obstetrics Hospitals Humans Hypertension Hypertension, Pregnancy-Induced - diagnostic imaging Hypertension, Pregnancy-Induced - epidemiology Hypertension, Pregnancy-Induced - physiopathology imaging Investigative techniques, diagnostic techniques (general aspects) Medical sciences Obstetrics Pre-eclampsia Pregnancy Pregnancy Trimester, First Pregnancy-Associated Plasma Protein-A - analysis Pregnancy. Fetus. Placenta Regression analysis screening Ultrasonic investigative techniques Ultrasonography, Doppler, Color - standards Ultrasonography, Doppler, Color - utilization Ultrasonography, Prenatal - standards Ultrasonography, Prenatal - utilization Ultrasound uterine artery Doppler Uterus Uterus - blood supply |
title | Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T23%3A56%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypertensive%20disorders%20in%20pregnancy:%20screening%20by%20uterine%20artery%20Doppler%20at%2011%E2%80%9313%20weeks&rft.jtitle=Ultrasound%20in%20obstetrics%20&%20gynecology&rft.au=Poon,%20L.%20C.%20Y.&rft.date=2009-08&rft.volume=34&rft.issue=2&rft.spage=142&rft.epage=148&rft.pages=142-148&rft.issn=0960-7692&rft.eissn=1469-0705&rft_id=info:doi/10.1002/uog.6452&rft_dat=%3Cproquest_cross%3E733574689%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017973290&rft_id=info:pmid/19644947&rfr_iscdi=true |